Biotech Breakthroughs

Results

56

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$551.25	2.9%	87.4%	US$12.6b	US$680.00	11.2	59.6%	n/a	Pharmaceuticals & Biotech
	SNDX	US$20.52	-7.9%	114.4%	US$1.8b	US$39.45	8.4	68.1%	n/a	Pharmaceuticals & Biotech
	ARDX	US$5.06	-0.6%	18.2%	US$1.2b	US$16.30	2.9	56.0%	n/a	Pharmaceuticals & Biotech
	ANAB	US$53.61	6.6%	101.6%	US$1.6b	US$87.09	6.8	48.1%	42.0%	Pharmaceuticals & Biotech
	MRKR	US$1.22	-4.7%	-21.3%	US$20.3m	US$7.87	5.7	69.0%	n/a	Pharmaceuticals & Biotech
	FRMM	US$5.54	-8.6%	-81.0%	US$75.7m	US$9.50	7.8	127.7%	n/a	Pharmaceuticals & Biotech
	NTLA	US$10.67	-2.3%	-18.6%	US$1.5b	US$26.17	22.6	67.9%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.59	-6.8%	-70.2%	US$91.7m	US$7.17	2.3	66.9%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.77	-5.9%	-1.3%	US$168.2m	US$4.00	742.2	60.9%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.97	11.7%	-22.8%	US$39.0m	US$7.03	29.2	73.0%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.18	-1.0%	129.7%	US$626.2m	US$13.80	59.4	64.3%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.03	-6.4%	-12.0%	US$256.8m	US$5.50	17.4	72.2%	n/a	Pharmaceuticals & Biotech
	CAPR	US$7.00	-64.1%	3.0%	US$1.1b	US$49.44	1.5	64.5%	n/a	Pharmaceuticals & Biotech
	CGON	US$73.52	4.7%	184.3%	US$6.1b	US$90.69	1278.8	61.1%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.30	2.2%	-3.0%	US$221.2m	US$8.56	50.5	47.1%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.61	1.4%	-62.8%	US$19.0m	US$7.15	15.9	55.5%	n/a	Pharmaceuticals & Biotech
	VRDN	US$19.70	6.1%	14.1%	US$2.1b	US$36.13	30.7	60.9%	n/a	Pharmaceuticals & Biotech
	ARQT	US$27.84	1.1%	86.1%	US$3.4b	US$34.63	8.4	48.1%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.67	2.7%	-72.7%	US$168.5m	US$2.05	90.2	60.9%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.56	-2.5%	-70.3%	US$52.3m	US$4.00	9.2	59.9%	n/a	Pharmaceuticals & Biotech
	LRMR	US$3.83	0%	5.2%	US$417.5m	US$14.40	2.5	52.5%	n/a	Pharmaceuticals & Biotech
	VERA	US$35.18	-4.9%	68.6%	US$2.5b	US$81.79	5.1	63.8%	n/a	Pharmaceuticals & Biotech
	NAMS	US$30.22	1.9%	29.0%	US$3.5b	US$50.73	156.6	64.3%	n/a	Pharmaceuticals & Biotech
	INSM	US$104.73	-2.1%	2.9%	US$23.2b	US$196.18	27.7	67.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 2